US Patent Issued to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) on July 21 for "HPK1 inhibitor, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,689, issued on July 21, was assigned to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) Co. LTD. (Shanghai).

"HPK1 inhibitor, preparation method therefor and use thereof" was invented by Yuli Xie (Shanghai), Houxing Fan (Shanghai) and Lihui Qian (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound of general formula (1) and a preparation method therefor and use of the compound of general formula (1) or isomers, crystalline forms, pharmaceutically acceptable salts, hydrates or solvates thereof as an HPK1 inhibitor. The compound of the present invention can be used for preparing a medicament for treating or prev...